This Government Contract opportunity was posted on December 16, 2011. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

NIAID Division of Allergy, Immunology and Transplantation: Clinical Site Monitoring Center

Awarded

RFP-NIAID-DAIT-NIHAI2010032Federal

Submission Closed12/16/2011, 12:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 541711

New

Federal

MANAGE AND OPERATE THE NATIONAL RENEWABLE ENERGY LABORATORYThe Department of Energy, through the Golden Field Office, is forecasting a contract for the management and operation of the National Renewable Energy Laboratory located in Colorado. This initiative falls under NAICS code 541711, focusing on research and development in the physical, engineering, and natural sciences. The procurement is listed as a forecast with a posted date of October 18, 2026. Interested parties may coordinate with Yolanda Dixon, the Small Business Program Manager, regarding this opportunity.

POSTED

DEADLINE

Research Subaward / Collaborative Research PartnerThis subcontract establishes a collaborative research partnership to support prime contractors on research projects funded by the National Science Foundation and UK Research and Innovation, specifically under the Arts and Humanities Research Council. The selected partner is responsible for executing specialized research tasks, including data collection and analysis, following project-defined methodologies to solve specific research challenges and support planned outputs. Key deliverables include the provision of research data, detailed analysis reports, and contributions to final publications. To ensure compliance, all work must adhere to the NSF Grant Policy Manual and established UKRI funding norms. The engagement is categorized under NAICS code 541711, focusing on research and experimental development in the natural sciences and engineering.

Arts and Humanities Research Council (AHRC)

POSTED

DEADLINE

Research Collaboration and Laboratory AnalysisThe Research Collaboration and Laboratory Analysis subcontract is issued by the National Institute of Food and Agriculture under the Department of Agriculture. This agreement focuses on supporting grant recipients of the USDA-NIFA 1890 Capacity Building Grant Program through the execution of research tasks, data collection, and laboratory analysis. The scope of work includes conducting field trials and laboratory testing to meet specific scientific objectives, with required deliverables consisting of research data sets, technical reports, and peer-reviewed publications. Classified under NAICS code 541711, the opportunity was posted on September 3, 2026, with a response deadline of November 4, 2026. This subcontract is designed to provide essential technical and analytical support to ensure the successful completion of research goals within the specified grant program.

National Institute Of Food And Agriculture

POSTED

DEADLINE

Novel In-Situ Binder Chemistry DevelopmentThe NASA SBIR/STTR Program is seeking a subcontractor for the development of a novel in-situ binder chemistry designed for use on the Moon or Mars. The primary objective of this project is to create a binder sourced entirely from lunar or Martian regolith that can cure without the need for external energy input. The scope of work encompasses the initial formulation, lab-scale testing, and subsequent optimization of the chemistry to ensure viability for extraterrestrial construction. This opportunity is designated as a Total Small Business Set-Aside under the SBIR/STTR mandate, specifically for firms with fewer than 500 employees. The work will be performed at the Kennedy Space Center, falling under NAICS code 541711 for research and development in biotechnology. The solicitation was posted on August 20, 2026, as part of NASA's efforts to advance sustainable infrastructure capabilities for deep space exploration.

NASA SBIR/STTR Program

POSTED

DEADLINE

High-Throughput Serology Assay DevelopmentThe contract requires the design, validation, and delivery of a high-throughput serology platform intended to match or surpass the performance of the current hemagglutination inhibition (HAI) assay used for influenza surveillance. The platform must be scalable and robust enough to support large-scale, rapid serological testing, ensuring accurate and consistent data collection for public health monitoring. Development must adhere to stringent performance benchmarks, with a focus on improving throughput, precision, and reproducibility across diverse influenza strains and sample types. This is a subcontract under the Department of Defense’s FA9000 AFGPO program, with performance centered at DWG. The North American Industry Classification System code 541711 indicates it falls under research and development in the physical, engineering, and life sciences. The solicitation was posted on June 15, 2026, and the work is expected to advance the DoD’s capability in infectious disease surveillance by replacing aging laboratory methods with a next-generation automated system. While no set-aside or point of contact details are provided, the project’s success is critical to maintaining national-level preparedness for seasonal and pandemic influenza threats.

POSTED

DEADLINE

Engineering & Scientific Research SupportThe contract entails providing engineering analysis, research and development, and technical support specifically focused on F-15 aircraft systems, encompassing avionics, propulsion, and weapons integration. The work involves activities such as modeling, simulation, and the formulation of test plans to support enhancements and maintenance of these complex systems. Issued by the Department of Defense under the NAICS code 541711, this subcontract titled "Engineering & Scientific Research Support" is designed to advance the technical capabilities and reliability of the F-15 platform. While certain logistical details like the exact place of performance and point of contact are not specified, the contract underscores a commitment to rigorous scientific and engineering efforts to ensure mission readiness and technological superiority for this key military asset.

FA8622 Aflcmc Azs Epass

POSTED

DEADLINE

Technical Research and Analysis (Science & Technology Focus)This contract involves conducting advanced technical research across physical, engineering, and life sciences disciplines to support innovation and technology development within the defense sector. It is a subcontract opportunity issued by the Department of Defense through Washington Headquarters Services, aimed at advancing scientific and technological capabilities that bolster defense-related projects and initiatives. Designated as a Total Small Business Set-Aside under SBA regulations, the contract falls under NAICS code 541711, which pertains to research and development in the physical, engineering, and life sciences. The work is to be performed in Washington, reflecting a focus on high-impact, cutting-edge research that addresses critical defense challenges. This opportunity emphasizes the Department of Defense's commitment to engaging small businesses in strategic research efforts that drive forward defense technology and innovation.

Washington Headquarters Services

POSTED

DEADLINE

Vehicle Recompete: IGF::OT::IGF ID/IQ PARENT AWARD FOR PHARMACOLOGY AND TOXICOLOGY FOR… — INDEFINITE DELIVERY / INDEFINITE QUANTITY NIHNINDS1601This Indefinite Delivery/Indefinite Quantity parent award supports the Pharmacology and Toxicology for Therapeutics Program under the National Institutes of Health. The vehicle, identified by solicitation NIHNINDS1601, has an ordering period that extends through September 12, 2027. It is currently classified as a full recompete and is associated with two primary awards, HHSN271201600006I and HHSN271201600007I. There are currently 18 active task orders with a total combined value of over 18.7 million dollars. SRI International is the dominant incumbent, holding 15 orders totaling approximately 17.1 million dollars, with significant funding dedicated to continuous rodent and non-rodent pharmacokinetic assessments and GLP toxicology studies. Southern Research Institute holds the remaining three orders, valued at approximately 1.66 million dollars.

National Institutes of Health

POSTED

DEADLINE

Biotechnology and Life Sciences R&DThis subcontract, issued by the Department of Defense's AFRL Headquarters, focuses on biotechnology and life sciences research and development with an emphasis on defense-related applications. The scope involves advancing technologies such as bio-sensing, enhancing human performance, and developing medical countermeasures to support military readiness and resilience. The contract falls under the NAICS code 541711, which pertains to research and development in the physical, engineering, and life sciences. Although certain logistical details like specific location and points of contact are not provided, the work aims to contribute cutting-edge biotechnological innovations for national defense purposes. The solicitation was posted in January 2026, indicating a current opportunity for entities capable of delivering advanced R&D services in these specialized fields, collaborating closely with the Department of Defense to address evolving defense challenges through scientific and technological efforts.

FA8652 Afrl Hq Afrl/pk

POSTED

DEADLINE

Green Chemistry R&D Support

California Toxic Substances Control, Department of

POSTED

10 months ago

DEADLINE

N/A

AI Contract Overview

The NIAID Division of Allergy, Immunology and Transplantation is establishing a Clinical Site Monitoring Center to provide comprehensive monitoring services for clinical research studies. The primary objective is to ensure strict compliance with regulatory standards, including Title 21 CFR Part 312, Title 45 CFR Part 46 regarding Human Subjects Protection, and ICH/GCP guidelines. These services support the Immune Tolerance Network and other DAIT-funded programs, including investigator-initiated studies conducted under grants. The scope of work covers Phase I through IV trials, as well as epidemiological, mechanistic, and natural history or observational studies. The contract encompasses a wide range of immune-mediated diseases, such as autoimmune disorders, asthma, allergic diseases, and organ transplantation rejection. Monitoring will be conducted across single- and multicenter sites located within the United States and internationally, specifically in Australia, the United Kingdom, Western Europe, and the Americas.

General Info

Agency

N/A

Contract Value

$27,036,076.33

NAICS

541711 - Research and Development in Biotechnology

Place of Performance

NC, USA

Set-Aside

NONE

Awardee

PPD DEVELOPMENT LP

Award Issued Date

12/16/2011, 12:00:00 AM UTC

Documents

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

2 updates

PhaseAwarded

PostedOct 28

Presolicitation

Notice updatedNov 18

The notice description changed.

Notice updatedJan 10

Notice details unchanged. Attachments may have changed.

Type ChangedJan 25

Presolicitation → Solicitation

AwardedDec 16

Contract was awarded

Submission Closed

12/16/2011, 12:00:00 PM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyN/A

Contacts2 people available

OfficeN/A

Organization / Agency

N/A

Office AddressN/A

Contacts

MyLinh PhamContract Specialist

contact@example.gov

+1 (555) 000-0000

David T. LisleContracting Officer

contact@example.gov

+1 (555) 000-0000

Full Description

This initiative will provide DAIT with comprehensive clinical site monitoring services to fulfill its responsibilities as the funder and/or sponsor of clinical research studies conducted by the immune tolerance network(ITN) by ensuring compliance with applicable regulations, including Title 21 Code of Federal Regulations (CFR) Part 312, Human Subjects Protection Title 45 CFR Part 46, and E6 International Conference on Harmonization good Clinical Practices (ICH/GCP). In addition, Clinical Site monitoring services will include DAIT-supported, investigator-initiated clinical research studies conducted under grants, as well as other DAIT-funded clinical research programs on a limited, as-needed basis. These services will be provided for single-and multicenter sites in the U.S. and international sites, including sites in the Americas, the United Kingdom, Western Europe, and Australia. Types of studies: Phase I - IV; epidemiological; mechanistic; natural history/observational. Diseases under evaluation: immune mediated, diverse and complex (asthma and allergic diseases; autoimmune disorders; and immune-mediated rejection in solid organ, tissue and cell transplantation).

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Join 750+ contractors already using CLEATUS